Making the Distress of Chemotherapy Easier on Your Stomach and Wallet

Please Bookmark:

Zofran was the first drug of its kind to be approved by the food and drug administration and made available to the public, and it has since been approved to alleviate the nausea and vomiting caused by surgery. Zofran has become one of the top choices for anesthesiologists to prescribe in accordance with the prevention of the nausea and vomiting that are sometimes common after effects associated with surgical procedures.

The stomach sickness associated with chemotherapy is a big concern for cancer sufferers. I’ve seen cancer patients following chemotherapy sessions, broken down in physical illness with a severely upset stomach and bouts of vomiting, sick for a day or more after the session. I’ve even heard of people unwilling to undergo the treatment for fear of being unable to enjoy any time between treatments, fear of being sick all the time. Any delay in the treatment of cancer can have a significantly negative effect how the well the treatment works. A drug like Zofran allows cancer patients to focus on the treatment of the disease rather than the unpleasantness associated with what they would have had to have dealt with after, allowing them to actually live their lives in between treatment sessions and giving them the possibility of feeling good while doing so.

The side effects of Zofran are said to generally mild and may include: headache, diarrhea, constipation and fever. Zofran was the twentieth best selling drug in the United States in 2005 with sales of more than eight hundred million dollars.

It was estimated the nearly forty-five percent of patients undergoing chemotherapy weren’t getting the support they needed in this important area of their treatment, either walking away with no prescription to combat the nausea and vomiting, or not getting the most effective prescription for the problem. It’s believed that some of these people were suffering due to the cost of the prescription and veritable lack of a decent alternative.

In December of 2006 the US food and drug administration approved the first generic versions of the drug Zofran. License to produce generic versions of the drug was granted to three U.S. companies. According to the FDA these less expensive versions of the drug are now being used to fill more than fifty percent of all prescriptions, the FDA also adds that the generic versions are identical to their brand name counterparts in: dosage, strength, route of administration, quality, performance and intended use.

The introduction of generic forms of this drug make it much more readily available to those who may not have been able to get it before, allowing them to begin whatever form of treatment is right for then without being hampered by the inherent fear that the treatment would prove to be worse than the disease.